Obestatin: An interesting but controversial gut hormone

Annals of Nutrition and Metabolism

Volumn 59, Issue 2-4, 2011, Pages 193-199

  Lacquaniti, Antonio ^a   Donato, Valentina ^a   Chirico, Valeria ^a   Buemi, Antoine ^a   Buemi, Michele ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Cancer; Diabetes mellitus; Food intake; Obesity; Obestatin

Indexed keywords

ARABINOSIDE; OBESTATIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANOREXIA NERVOSA; APOPTOSIS; APPETITE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BODY MASS; CELL PROLIFERATION; CORTICOSTERONE RELEASE; FOOD INTAKE; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; INSULIN RELEASE; INTESTINE MOTILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS JUICE; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING; WEIGHT GAIN;

EID: 83155168290     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000334106     Document Type: Review

References (50)

1. Zhao CM, Furnes MW, Stenstrom B, et al: Characterization of obestatin-And ghrelinproducing cells in the gastrointestinal tract and pancreas of rats: An immunohistochemical and electron-microscopic study. Cell Tissue Res 2008; 331: 575-587.
2. Kirchner H, Gutierrez JA, Solenberg PJ, et al: GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009; 15: 741-745.
3. Liu J, Prudom CE, Nass R, et al: Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab 2008; 93: 1980-1987.
4. Gronberg M, Tsolakis AV, Magnusson L, et al: Distribution of obestatin and ghrelin in human tissues: Immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 2008; 56: 793-801.
5. Aydin S, Ozkan Y, Erman F, et al: Presence of obestatin in breast milk: Relationship among obestatin, ghrelin, and leptin in lactating women. Nutrition 2008; 24: 689-693.
6. Gualillo O, Lago F, Casanueva FF, et al: One ancestor, several peptides post-translational modifications of preproghrelin generate several peptides with antithetical effects. Mol Cell Endocrinol 2006; 256: 1-8.
7. Zhang JV, Ren PG, Avsian-Kretchmer O, et al: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999.
8. Zhang JV, Jahr H, Luo CW, et al: Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol 2006; 22: 1464-1475.
9. Chartrel N, Alvear-Perez R, Leprince J, et al: Comment on 'Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake'. Science 2007; 315: 766.
10. Granata R, Settanni F, Gallo D, et al: Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008; 57: 967-979.
11. Yamamoto H, Kishi T, Lee CE, et al: Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci 2003; 23: 2939-2946.
12. Holst JJ: The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
13. Zizzari P, Longchamps R, Epelbaum J, et al: Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 2007; 148: 1648-1653.
14. Ariysu H, Takaya K, Tagami T: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-4758.
15. Carlini VP, Schioth HB, Debarioglio SR: Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 2007; 352: 907-912.
16. Szentirmai E, Krueger JM: Obestatin alters sleep in rats. Neurosci Lett 2006; 404: 222-226.
17. Camiña JP, Campos JF, Caminos JE, et al: Obestatin-mediated proliferation of human retinal pigment epithelial cells: Regulatory mechanisms. J Cell Physiol 2007; 211: 1-9.
18. Mészãrosovã M, Sirotkin AV, Grossmann R, et al: The effect of obestatin on porcine ovarian granulosa cells. Anim Reprod Sci 2008; 108: 196-207.
19. Pazos Y, Alvarez CJ, Camiña JP, et al: Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 2007; 25: 373-381.
20. Kapica M, Zabielska M, Puzio I, et al: Obestatin stimulates the secretion of pancreatic juice enzymes through a vagal pathway in anaesthetized rats -preliminary results. J Physiol Pharmacol 2007; 58: 123-130.
21. Ren AJ, Guo ZF, Wang YK, et al: Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochim Biophys Res Commun 2008; 369: 969-972.
22. Banks WA, Tschop M, Robinson SM, et al: Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002; 302: 822-827.
23. Pan W, Tu H, Kastin AJ: Differential BBB interactions of three ingestive peptides: Obestatin, ghrelin, and adiponectin. Peptides 2006; 27: 911-916.
24. Bresciani E, Rapetti D, Donà F, et al: Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 2006; 29: 16-18.
25. Yamamoto D, Ikeshita N, Daito R, et al: Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL TSH and ACTH in rats. Regul Pept 2007; 138: 141-144.
26. Samson WK, White MM, Price C, et al: Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 2007; 292: 637-643.
27. Samson WK, Yosten G, Chang JK, et al: Obestatin inhibits vasopressin secretion: Evidence for a physiological action in the control of fluid homeostasis J Endocrinol 2008; 196: 559-564.
28. Nogueiras R, Pfluger P, Tovar S, et al: Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007; 148: 21-26.
29. Gourcerol G, Tache Y: Obestatin -A ghrelinassociated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil 2007; 19: 161-165.
30. Huda MS, Durham BH, Wong SP, et al: Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes 2008; 32: 129-135.
31. Zamrazilovã H, Hainer V, Sedlãckovã D, et al: Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res 2008; 57: 49-55.
32. Nakahara T, Harada T, Yasuhara D, et al: Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 2008; 64: 252-255.
33. Mafra D, Guebre-Egziabher F, Cleaud C, et al: Obestatin and ghrelin interplay in hemodialysis patients, Nutrition 2010; 26: 1100-1104.
34. Lacquaniti A, Bolignano D, Donato V, et al: Obestatin: A new element for mineral metabolism and inflammation in patients on hemodialysis. Kidney Blood Press Res 2011; 34: 104-110.
35. Lacquaniti A, Donato V, Chirico V, et al: From chronic kidney disease to transplantation: The roles of obestatin. Regul Pept 2011; 171: 48-52.
36. Zou CC, Liang L, Wang CL, Fu JF, Zhao ZY: The change in ghrelin and obestatin levels in obese children after weight reduction. Acta Paediatr 2009; 98: 159-165.
37. Butler MG, Bittel DC: Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Genet 2007; 143: 413-414.
38. Qader SS, Håkanson R, Rehfeld JF, et al: Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: A study on isolated islets from mouse and rat pancreas. Regul Pept 2008; 146: 230-237.
39. Egido EM, Hernãndez R, Marco J, Silvestre RA: Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 2009; 152: 61-66.
40. Fontenot E, DeVente JE, Seidel ER: Obestatin and ghrelin in obese and in pregnant women. Peptides 2007; 28: 1937-1944.
41. Kellokoski E, Kunnari A, Jokela M, et al: Ghrelin and obestatin modulate early atherogenic processes on cells: Enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metab Clin Exp 2009; 58: 1572-1580.
42. Ozbay Y, Aydin S, Dagli AF, et al: Obestatin is present in saliva: Alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease. BMB Reports 2008; 41: 55-61.
43. Ren AJ, He Q, Shi JS, et al: Association of obestatin with blood pressure in the third trimesters of pregnancy. Peptides 2009; 30: 1742-1745.
44. Alvarez CJ, Lodeiro M, Theodoropoulou M, et al: Obestatin stimulates Akt signaling in gastric cancer cells through beta-Arrestinmediated epidermal growth factor receptor transactivation. Endocr Relat Cancer 2009; 16: 599-611.
45. Volante M, Rosas R, Ceppi P, et al: Obestatin in human neuroendocrine tissues and tumours: Expression and effect on tumour growth. J Pathol 2009; 218: 458-466.
46. Iglesias MJ, Salgado A, Piñeiro R, et al: Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. J Endocrinol Invest 2007; 30: 470-476.
47. Zhang Z, Zou D, Chen Y, et al: Obestatin inhibits proliferation and differentiation of 3T3-L1 preadipocytes. Acad J Sec Mil Med Univ 2007; 28: 929-932.
48. Alnema MM, Aydin S, Ozkan Y, et al: Ghrelin and obestatin expression in oral squamous cell carcinoma: An immunohistochemical and biochemical study. Mol Cell Biochem 2010; 339: 173-179.
49. Chen C, Asakawa A, Fujimiya M, Lee S, Inui A: Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 2009; 61: 430-481.
50. Perboni S, Inui A: Appetite and gastrointestinal motility: Role of ghrelin-family peptides. Clin Nutr 2010; 29: 227-234.s